Sean Cao

Corporate Officer/Principal bei NOVABRIDGE BIOSCIENCES

Vermögen: 29 730 $ am 30.06.2026

59 Jahre

74 Beziehungen

Health Technology

Consumer Services

Finance

Profil

Sean Wuxiong Cao was the founder of Everest Medicines Ltd., founded in 2017, where the title held was CEO from 2017 to 2020.
Dr. Cao is also the founder of Abio-X Holdings, Inc...
Current jobs include Managing Director at CBC Group (Singapore) Pte.
Ltd. since 2016, Director at NiKang Therapeutics, Inc., and Chief Business Development Officer at NovaBridge Biosciences starting in 2026.
Former jobs include Chief Executive Officer & Director at ENSEM Therapeutics, Inc., Director at Aureon Biosciences, Inc. from 2009 to 2010, Manager-Product Development at Johnson & Johnson in 2008, Associate at New Leaf Venture Partners LLC from 2008 to 2009, and Senior Research Investigator at Sanofi-Aventis U.S.
LLC from 2001 to 2004.
Education includes an MBA from the University of Pennsylvania, a doctorate from Nankai University, and a doctorate from the University of Virginia conferred in 1990.

Bekannte Unternehmensbeteiligungen

Unternehmen	Datum	Anzahl der Aktien	Bewertung	Datum der Bewertung
NOVABRIDGE BIOSCIENCES 0.02%	22.06.2026	35’073 ( 0.02% )	29 730 $	30.06.2026

Aktive Positionen von Sean Cao

Unternehmen	Position	Beginn
NOVABRIDGE BIOSCIENCES	Corporate Officer/Principal	03.09.2025
NiKang Therapeutics, Inc. NiKang Therapeutics, Inc. BiotechnologyHealth Technology Develops small molecule oncology medicines to help patients	Direktor/Vorstandsmitglied	-
CBC Group (Singapore) Pte. Ltd. CBC Group (Singapore) Pte. Ltd. Investment ManagersFinance CBC Group invests in middle market companies located in China. The firm focuses on pharmaceutical, biotechnology, medical technology and healthcare service sectors. It provides financing in the form of equity, debt and non-dilutive financing for for buyout, growth, royalty acquisitions, structured transactions and hybrid financings. It acquires controlling stake in the company.	Direktor/Vorstandsmitglied	01.10.2016
Abio-X Holdings, Inc.	Vorstandsvorsitzender	-

Alle aktiven Positionen von Sean Cao

Ehemalige bekannte Positionen von Sean Cao

Unternehmen	Position	Ende
ENSEM Therapeutics, Inc. ENSEM Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops molecule precision medicines for oncology	Vorstandsvorsitzender	05.06.2023
EVEREST MEDICINES LIMITED	Vorstandsvorsitzender	01.02.2020
Aureon Biosciences, Inc. Aureon Biosciences, Inc. BiotechnologyHealth Technology Develops predictive tests for cancer recurrence and provides contract research services	Direktor/Vorstandsmitglied	01.03.2010
New Leaf Venture Partners LLC New Leaf Venture Partners LLC Investment ManagersFinance New Leaf Ventures invests in public and private healthcare technology companies located in the US. The firm participates in early and later-stage capital requirements.	Private-Equity-Analyst	01.09.2009
New Leaf Venture Partners LLC New Leaf Venture Partners LLC Investment ManagersFinance New Leaf Ventures invests in public and private healthcare technology companies located in the US. The firm participates in early and later-stage capital requirements.	Private-Equity-Analyst	31.08.2009

Sehen Sie sich die Erfahrung von Sean Cao im Detail an

Ausbildung von Sean Cao

Erfahrungen
Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Sehen Sie sich die Erfahrung von Sean Cao im Detail an

Beziehungen

Beziehungen ersten Grades

Unternehmen ersten Grades

Herr

Frau

Aufsichtsräte

Führungskräfte

Sehen Sie sich das persönliche Netzwerk an

Unternehmensverbindungen

Private Unternehmen	13
Johnson & Johnson Johnson & Johnson Pharmaceuticals: MajorHealth Technology Operates as an investment holding company with interests in health care products	Health Technology
Aureon Biosciences, Inc. Aureon Biosciences, Inc. BiotechnologyHealth Technology Develops predictive tests for cancer recurrence and provides contract research services	Health Technology
University of Virginia University of Virginia Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
University of Pennsylvania University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
New Leaf Venture Partners LLC New Leaf Venture Partners LLC Investment ManagersFinance New Leaf Ventures invests in public and private healthcare technology companies located in the US. The firm participates in early and later-stage capital requirements.	Finance
Nankai University Nankai University Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Sanofi-Aventis U.S. LLC Sanofi-Aventis U.S. LLC Pharmaceuticals: MajorHealth Technology Develops medicines, vaccines and provides specialized healthcare & clinical trail services	Health Technology
CBC Group (Singapore) Pte. Ltd. CBC Group (Singapore) Pte. Ltd. Investment ManagersFinance CBC Group invests in middle market companies located in China. The firm focuses on pharmaceutical, biotechnology, medical technology and healthcare service sectors. It provides financing in the form of equity, debt and non-dilutive financing for for buyout, growth, royalty acquisitions, structured transactions and hybrid financings. It acquires controlling stake in the company.	Finance
Everest Medicines Ltd. Everest Medicines Ltd. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company which develops and commercializes therapies to address critical unmet medical needs	Health Technology
I-Mab I-Mab Pharmaceuticals: MajorHealth Technology Develops and manufactures medicines for cancer and autoimmune diseases	Health Technology
NiKang Therapeutics, Inc. NiKang Therapeutics, Inc. BiotechnologyHealth Technology Develops small molecule oncology medicines to help patients	Health Technology
ENSEM Therapeutics, Inc. ENSEM Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops molecule precision medicines for oncology	Health Technology
Abio-X Holdings, Inc.